mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-08 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-08 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-08 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-08 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-08 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-07 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-07 |